OC
TCBC

Oppenheimer & Close’s TC Bancshares, Inc. Common Stock TCBC Stock Holding History

Oppenheimer & Close’s Portfolio TCBC Stock Details TCBC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-43,000
Closed -$581K – 55
2024
Q2 		$581K Hold
43,000
– – 0.51% 44
2024
Q1 		$591K Hold
43,000
– – 0.51% 41
2023
Q4 		$594K Hold
43,000
– – 0.54% 42
2023
Q3 		$585K Buy
43,000
+6,680
+18% +$94K 0.58% 40
2023
Q2 		$519K Buy
36,320
+11,320
+45% +$159K 0.54% 41
2023
Q1 		$364K Hold
25,000
– – 0.36% 51
2022
Q4 		$373K Hold
25,000
– – 0.37% 54
2022
Q3 		$359K Hold
25,000
– – 0.39% 55
2022
Q2 		$340K Hold
25,000
– – 0.39% 50
2022
Q1 		$352K Hold
25,000
– – 0.3% 50
2021
Q4 		$333K Sell
25,000
-2,200
-8% -$29.9K 0.31% 54
2021
Q3 		$379K Buy
+27,200
New +$345K 0.36% 56

Other funds holding TCBC

MCM
Maltese Capital Management New York $508M AUM 21.31% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

Oppenheimer & Close's TCBC Position: Q3 2024 in Review

Oppenheimer & Close sold out of TC Bancshares, Inc. Common Stock (TCBC) in Q3 2024, closing a stake of 43,000 shares — an estimated $581K sold.

Oppenheimer & Close first reported a position in TCBC in Q3 2021 and held it in 12 quarters. The position peaked at $594K in Q4 2023. 3 funds tracked by Wall St. Rank hold TCBC as of Q3 2024.

  • Oppenheimer & Close reported no remaining TC Bancshares, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Oppenheimer & Close sold 43,000 TC Bancshares, Inc. Common Stock shares in Q3 2024, an estimated $581K.
  • Oppenheimer & Close first reported a position in TC Bancshares, Inc. Common Stock in Q3 2021 and held it in 12 quarters.
  • Oppenheimer & Close's TC Bancshares, Inc. Common Stock position peaked at $594K in Q4 2023.
  • 3 funds tracked by Wall St. Rank held TC Bancshares, Inc. Common Stock as of Q3 2024.

Based on Oppenheimer & Close's 13F filing for Q3 2024, filed 17 Oct 2024.